Latest Ratios: P/E Ratio 11.5x · EV/EBITDA 8.2x · ROE 8.0%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $7.4B | $7.4B | $10.8B | $10.7B | $10.2B | $16.6B | $13.7B | $11.0B | $10.4B | $13.5B | $11.2B |
| Enterprise Value | $11.9B | $11.9B | $15.2B | $15.3B | $14.8B | $21.6B | $18.7B | $16.6B | $16.4B | $19.9B | $17.6B |
| P/E Ratio → | 11.48 | 15.57 | 11.91 | 11.99 | 12.83 | 19.35 | 28.65 | 14.46 | 9.67 | 9.18 | 12.88 |
| P/S Ratio | 0.81 | 0.84 | 1.15 | 1.17 | 0.97 | 1.58 | 1.62 | 1.19 | 1.03 | 1.42 | 1.25 |
| P/B Ratio | 1.23 | 1.22 | 1.84 | 1.94 | 1.94 | 2.86 | 2.24 | 1.82 | 1.78 | 2.43 | 2.42 |
| P/FCF | 15.70 | 17.40 | 15.65 | 19.64 | 27.94 | 15.92 | 12.93 | 10.23 | 10.29 | 13.43 | 14.71 |
| P/OCF | 7.59 | 7.61 | 8.37 | 7.81 | 10.43 | 10.24 | 9.41 | 7.30 | 6.77 | 8.17 | 8.06 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.36 | 1.62 | 1.66 | 1.41 | 2.06 | 2.21 | 1.79 | 1.62 | 2.09 | 1.96 |
| EV / EBITDA | 8.25 | 8.23 | 8.06 | 9.61 | 9.50 | 10.78 | 11.03 | 8.56 | 7.89 | 9.41 | 8.28 |
| EV / EBIT | 12.76 | 15.32 | 11.74 | 11.70 | 12.80 | 16.99 | 25.50 | 14.82 | 10.62 | 13.01 | 13.17 |
| EV / FCF | — | 28.04 | 22.08 | 28.05 | 40.74 | 20.79 | 17.70 | 15.43 | 16.15 | 19.73 | 23.15 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 21.1% | 21.1% | 24.4% | 22.4% | 19.5% | 24.0% | 23.7% | 24.3% | 24.0% | 26.1% | 27.4% |
| Operating Margin | 10.6% | 10.6% | 14.7% | 11.9% | 10.3% | 14.0% | 13.3% | 14.3% | 14.6% | 16.1% | 17.2% |
| Net Profit Margin | 5.4% | 5.4% | 9.6% | 9.7% | 7.5% | 8.2% | 5.6% | 8.2% | 10.7% | 15.5% | 9.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 8.0% | 8.0% | 15.9% | 16.6% | 14.4% | 14.4% | 7.9% | 12.7% | 18.9% | 28.9% | 20.0% |
| ROA | 3.2% | 3.2% | 6.1% | 6.1% | 5.3% | 5.4% | 3.0% | 4.7% | 6.8% | 9.4% | 5.6% |
| ROIC | 6.7% | 6.7% | 10.1% | 8.2% | 7.8% | 10.0% | 7.4% | 8.5% | 9.3% | 10.0% | 10.6% |
| ROCE | 7.5% | 7.5% | 11.2% | 9.3% | 9.0% | 11.0% | 8.0% | 9.3% | 10.5% | 11.0% | 11.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.84 | 0.84 | 0.90 | 0.93 | 0.98 | 0.95 | 0.92 | 0.96 | 1.05 | 1.17 | 1.43 |
| Debt / EBITDA | 3.52 | 3.52 | 2.79 | 3.22 | 3.30 | 2.75 | 3.31 | 2.99 | 2.97 | 3.09 | 3.11 |
| Net Debt / Equity | — | 0.75 | 0.76 | 0.83 | 0.89 | 0.87 | 0.83 | 0.92 | 1.01 | 1.14 | 1.39 |
| Net Debt / EBITDA | 3.12 | 3.12 | 2.35 | 2.88 | 2.98 | 2.52 | 2.97 | 2.88 | 2.86 | 3.00 | 3.02 |
| Debt / FCF | — | 10.64 | 6.43 | 8.41 | 12.80 | 4.86 | 4.77 | 5.20 | 5.85 | 6.30 | 8.45 |
| Interest Coverage | 3.73 | 3.73 | 5.99 | 5.82 | 6.16 | 6.64 | 3.59 | 5.05 | 6.48 | 6.26 | 5.17 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | 1.37 | 1.51 | 1.35 | 1.16 | 1.56 | 1.74 | 1.86 | 1.82 | 1.59 | 1.60 |
| Quick Ratio | 0.63 | 0.63 | 0.78 | 0.70 | 0.58 | 1.06 | 1.06 | 0.93 | 0.96 | 0.82 | 0.81 |
| Cash Ratio | 0.21 | 0.21 | 0.31 | 0.21 | 0.15 | 0.15 | 0.28 | 0.11 | 0.12 | 0.10 | 0.10 |
| Asset Turnover | — | 0.59 | 0.62 | 0.63 | 0.72 | 0.68 | 0.53 | 0.58 | 0.63 | 0.59 | 0.58 |
| Inventory Turnover | 3.49 | 3.49 | 3.57 | 4.24 | 4.48 | 5.30 | 4.68 | 4.21 | 4.86 | 4.66 | 4.62 |
| Days Sales Outstanding | — | 41.66 | 45.60 | 45.79 | 44.24 | 55.01 | 65.33 | 54.27 | 53.48 | 53.17 | 49.41 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 5.1% | 5.2% | 3.5% | 3.5% | 3.7% | 2.3% | 2.6% | 3.1% | 3.0% | 2.2% | 2.4% |
| Payout Ratio | 80.4% | 80.4% | 41.9% | 42.1% | 48.0% | 43.8% | 74.9% | 45.2% | 29.4% | 20.1% | 31.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.7% | 6.4% | 8.4% | 8.3% | 7.8% | 5.2% | 3.5% | 6.9% | 10.3% | 10.9% | 7.8% |
| FCF Yield | 6.4% | 5.7% | 6.4% | 5.1% | 3.6% | 6.3% | 7.7% | 9.8% | 9.7% | 7.4% | 6.8% |
| Buyback Yield | 1.4% | 1.4% | 2.8% | 1.4% | 9.9% | 6.0% | 0.4% | 3.0% | 3.8% | 2.6% | 1.3% |
| Total Shareholder Yield | 6.5% | 6.5% | 6.3% | 4.9% | 13.6% | 8.3% | 3.1% | 6.1% | 6.9% | 4.8% | 3.7% |
| Shares Outstanding | — | $116M | $118M | $119M | $125M | $137M | $137M | $139M | $143M | $146M | $148M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EMN stock.
Eastman Chemical Company's current P/E ratio is 11.5x. The historical average is 18.2x. This places it at the 21th percentile of its historical range.
Eastman Chemical Company's current EV/EBITDA is 8.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.6x.
Eastman Chemical Company's return on equity (ROE) is 8.0%. The historical average is 16.1%.
Based on historical data, Eastman Chemical Company is trading at a P/E of 11.5x. This is at the 21th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Eastman Chemical Company's current dividend yield is 5.12% with a payout ratio of 80.4%.
Eastman Chemical Company has 21.1% gross margin and 10.6% operating margin. Operating margin between 10-20% is typical for established companies.
Eastman Chemical Company's Debt/EBITDA ratio is 3.5x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
Persistent year-over-year revenue contraction
Metrics are mathematically derived from official filings.
Trailing Multiples Overstate Earnings Power
Based on EMN's reported figures, the trailing P/E of 16.03 compares with a forward P/E of 10.47, implying the market expects earnings to rise meaningfully from current trailing levels as the 2026 recovery takes hold.
The gap between trailing and forward earnings multiples suggests analysts view recent quarters as a cyclical trough rather than a new base, though the PEG of 4.98 indicates little growth-adjusted discount relative to expected expansion. Against an EV/EBITDA of 8.33 and a P/S of 0.86, the stock appears priced more like a commodity-linked intermediates producer than a specialty materials company, which may reflect skepticism about the durability of the circular-economy premium. Investors should monitor whether forward estimates hold, since the valuation case depends heavily on earnings normalization rather than current cash generation.
Margin Recovery Still Short of Prior Peak
As reported in financial statements, EMN's gross margin rebuilt from 17.1% in 2025Q4 to 22.3% in 2026Q2 and 2026Q3, yet remains below the 24.6% to 25.3% levels seen throughout 2024.
The operating margin path, falling from 16.8% in 2024Q4 to 6.1% in 2025Q4 before recovering to 12.1%, points to meaningful operating deleverage from a high fixed-cost base. The net margin of 10.6% in the latest quarter appears inflated relative to operating margin, suggesting below-the-line items or tax effects may be contributing, which warrants scrutiny before treating it as earning power. Sustained recovery toward 2024 margin levels would support a higher normalized earnings base, while failure to close the gap may indicate structural pressure from commodity intermediates.
Returns Rebuilding From a Compressed Base
According to recent SEC filings, EMN's ROIC has moved from 0.9% in 2025Q4 to 2.2% in 2026Q2 and 2.0% in 2026Q3, still well below the 2.6% to 2.8% range recorded through 2024.
The low absolute ROIC relative to a capital-intensive asset base of roughly $5.6B to $5.9B in net PP&E suggests the company has been earning returns below what its invested capital would ideally generate, particularly during the trough period. The ROE of 4.0% in 2026Q3 is modest and partly reflects a growing equity base, so improvement in returns depends on margin recovery rather than balance sheet changes alone. Investors may want to track whether ROIC can return to the mid-2% range on a sustained basis, as that would indicate the circular-economy investments are beginning to contribute.
Coverage Strong Despite Stable Debt Load
Based on EMN's reported figures, interest coverage improved from 1.23 in 2025Q4 to 5.45 in 2026Q3, while debt-to-equity held in a narrow 0.82 to 0.90 band across the ten-quarter window.
The sharp swing in interest coverage largely reflects the earnings trough rather than any change in debt service burden, since total debt has stayed between $5.0B and $5.3B throughout the period. Debt-to-EBITDA rising to 20.15 in 2025Q4 before falling to 12.36 illustrates how sensitive leverage optics are to quarterly earnings volatility, so trailing-period metrics may overstate risk at the trough. The more relevant question is whether EBITDA can sustain recent levels, because a return to trough-level earnings would likely push leverage metrics back into a range that could constrain financial flexibility.
Recovery Narrative Rests on Two Quarters
Based on EMN's reported quarterly figures, the bullish case depends on two consecutive quarters of improving margins and cash generation, a short window given trailing revenue still shows about -6.7% year-over-year contraction.
The most commonly misapplied ratio for a business like EMN is the forward P/E, because it assumes analyst earnings estimates will hold through a period of volume uncertainty and destocking; a forward multiple of 10.47 looks attractive only if estimates prove durable. A more appropriate lens would be normalized free cash flow yield across a full cycle, given that free cash flow margin swung from negative 11.0% in 2026Q1 to 8.2% in 2026Q3 due largely to working capital movements. The recovery thesis may be overstated if the restocking-driven volume gains fade, which would leave the stock trading on trailing earnings that have not yet demonstrated sustained normalization.